
Opinion|Videos|June 21, 2024
Challenges, Unmet Needs, and the Future of Advanced Urothelial Carcinoma Management
Author(s)Pedro Barata, MD, MSc, FACP
A key opinion leader addresses the persistent challenges and unmet needs in the management of advanced urothelial carcinoma, while offering their insight into the future direction and potential advancements within this rapidly evolving field of oncology.
Advertisement
Episodes in this series

- What are the remaining challenges and unmet needs in advanced urothelial carcinoma?
- What are some promising approaches currently under study, and your hopes/expectations for treatment over the next 5-10 years?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
NCCN Updates Breast Cancer Guidelines: Sacituzumab Govitecan for 1L TNBC
2
FDA Accepts BLA for Ivonescimab in Pretreated EGFR-Mutated NSCLC
3
FDA Grants FTD to GPRC5D Bispecific LBL-034 for R/R Multiple Myeloma
4
Multiomic Real-World Data Predict Outcomes in Metastatic Breast Cancer
5


















